Categories

Category: Uncategorized

THCB’s Bookclub, September 2020 – NEO.LIFE

By JESSICA DAMASSA & MATTHEW HOLT

The THCB Book Club is a discussion with leading health care authors, which will be released on the third Wednesday of every month.

This month we hosted Jane Metcalfe (Founder of NEO.LIFE) to talk about her 2020 book NEO.LIFE. You can get a copy of it here!

NEO.LIFE is a very unusual book. It’s over 25 very short chapters (ranging from 1 page to 78) which include interviews, concepts, art, science, science fiction, and one short story. All from different authors or groups of authors that are all edited into place by Jane Metcalfe and Brian Bergstein.

The topic is the future of humans! And the loose focus is on biotech, human engineering, and well watch along and get a copy!

You can see the video below (and the podcast version will be in our iTunes & Spotify channels very soon).

In October the THCB BookClub will feature Mike Magee’s book, Code Blue.

Health in 2 Point 00, Episode 151| MDLive (not?) IPOing, DTx Platform for Schizophrenia, & more

We are forgetting about health tech, and celebrating Chicago-oo! Just kidding, today on Health in 2 Point 00, Jess asks me about Truepill getting a 75M Series C after just closing their B, Sana Benefits getting $20.8M, and Decent getting $10M, both of which are in the space of health benefits & insurance for small business have raised funding, MDLive closing a $50M round for their Virtual Primary Care (but weren’t they going public?), Owl Insights getting $15M from Ascension and Blue Ventures, and Boehringer Ingelheim & Click Therapeutics working on a $500M deal together on a DTx platform for Schizophrenia patients. –Matthew Holt

Continue reading…

Will COVID-19 Force The South To Finally Confront Structural Racism Within Their Medicaid Programs?

By MIKE MAGEE

If you would like to visit the meeting place of America’s two great contemporary pandemics –COVID-19 and structural racism – you need only visit America’s Nursing Homes.

This should come as no surprise to Medical Historians familiar with our Medicaid program. Prejudice and bias were baked in well before the signing of Medicaid and Medicare on July 30, 1965.

President Kennedy’s efforting on behalf of health coverage expansion met stiff resistance from the American Medical Association and Southern states in 1960. Part of their strategic pushback was the endorsement of a state-run and voluntary offering for the poor and disadvantaged called Kerr-Mills. Predictably, Southern states feigned support, and enrollment was largely non-existent. Only 3.3% of participants nationwide came from the 10-state Deep South “Black Belt.”

Based on this experience, when President Johnson resurrected health care as a “martyr’s cause” after the Kennedy assassination, he carefully built into Medicaid “comprehensive care and services to substantially all individuals who meet the plan’s eligibility standards” by 1977. But by 1972, after seven years of skirmishes, the provision disappeared.

Continue reading…

Patient Identity and Patient Record Matching

By ADRIAN GROPPER and DEBORAH C. PEEL

September 4, 2020

Thank you, ONC for the opportunity you gave me to speak in June. Also, thank you for the format of your August meeting where the Zoom chat feature offered a wonderful venue for an inclusive commentary and discussion as the talks were happening. Beats lining up at the microphone any day.

Here is a brief recap of my suggestions, in no particular order:

Continue reading…

Health in 2 Point 00, Episode 150 | Sesquicentennial anniversary edition!

It’s Health in 2 Point 00’s 150th Episode or Sesquicentennial anniversary! On this episode, we have the return of Softbank money—$100M goes to Biofourmis platform for AI & Clinical Trials. Next, Amwell prices their IPO at $14-16 a share, and Grand Rounds raises $175 million led by the Carlyle Group. Finally, we have real foul play to report – former Zocdoc CEO Cyrus Massoumi filed a lawsuit accusing his fellow cofounders and CFO of foul play, so Jess asks me to dish the dirty details. —Matthew Holt

The Medical AI Floodgates Open, at a Cost of $1000 per Patient

By LUKE OAKDEN-RAYNER

In surprising news this week, CMS (the Centres for Medicare & Medicaid Services) in the USA approved the first reimbursement for AI augmented medical care. Viz.ai have a deep learning model which identifies signs of stroke on brain CT and automatically contacts the neurointerventionalist, bypassing the first read normally performed by a general radiologist.

From their press material:

Viz.ai demonstrated to CMS a significant reduction in time to treatment and improved clinical outcomes in patients suffering a stroke. Viz LVO has been granted a New Technology Add on Payment of up to $1,040 per use in patients with suspected strokes.

https://www.prnewswire.com/news-releases/vizai-granted-medicare-new-technology-add-on-payment-301123603.html

This is enormous news, and marks the start of a totally new era in medical AI.

Especially that pricetag!


Doing it tough

It is widely known in the medical AI community that it has been a troubled marketplace for AI developers. The majority of companies have developed putatively useful AI models, but have been unable to sell them to anyone. This has lead to many predictions that we are going to see a crash amongst medical AI startups, as capital runs out and revenue can’t take over. There have even been suggestions that a medical “AI winter” might be coming.

Continue reading…

#COVID19 Symptom Data Challenge

By FARZAD MOSTASHARI & INDU SUBAIYA

Applications for the #COVID19 Symptom Data Challenge close in three weeks! 

Amidst #COVID19, using analytic approaches to maximize available information and data is paramount. Hosted by Margolis Center, sponsored by Facebook Data for Good (@academics), and in partnership with the Joint Program in Survey Methodology, Carnegie Mellon University, and ResolveToSaveLives, the Challenge seeks to analytic approaches that utilize COVID-19 symptom data to develop insights into the trajectory of the novel coronavirus. 

Have a solution? Finalists can win up to $50k and the winning analytic approach will be featured on Facebook’s (@academics) Data For Good website!

Much, much more information is on the Challenge Website. Apply by 11:59:59 pm ET on September 29!

Much more about the Challenge Background in this interview or in this slack channel.

Official rules are here

Farzad Mostashari is CEO of Aledade, former National Coordinator for Health Information technology, and former Deputy Commissioner at the New York City Department of Health and Mental Hygiene. Indu Subaiya is the President at Catalyst @ Health 2.0

A New Kind of Labor Day

By KIM BELLARD

This is probably the strangest Labor Day in decades, perhaps ever.   Tens of millions of workers remain unemployed due to the COVID-19 pandemic.  Many of those who are still working are adapting to working from home.  Those who are back at their workplace, or never left, are coping with an array of new safety protocols. 

Those who work in the right industries – like the NBA – may get tested regularly but most workers have to figure out for themselves when to quarantine and when to get tested.  For many workers, such as health care workers, people of color, and workers with underlying health issues, going to work is literally a life-or-death calculation. 

No wonder that experts, like Dr. David B. Agus, are calling for companies to have Chief Health Officers. 

Labor Day was originally intended to celebrate the labor movement, but these days labor unions don’t have much to celebrate.  Only around 10% of U.S. workers belong to a labor union; both the number and the percent of unionized workers has been in steady decline over the past few decades. 

Now Labor Day is mainly an extra day off for most, the unofficial end to summer, and, this year, possibly the springboard to a new surge in COVID-19 cases, due to holiday celebrations.  Dr. Anthony Fauci warned:

Continue reading…

Why Primary Care Should Run the Healthcare System

By KEN TERRY

(This is the fourth in a series of excerpts from Terry’s new book, Physician-Led Healthcare Reform: a New Approach to Medicare for All, published by the American Association for Physician Leadership.)

Many other countries’ healthcare systems outperform ours for one simple reason: They place a much greater emphasis on primary care, which occupies the central place in their systems. “The evidence is that where you have more primary care physicians, where you coordinate care, and where you pay to keep people healthy, you get better outcomes at lower cost,” says David Nash, MD, founding dean of the College of Population Health, part of Thomas Jefferson University in Philadelphia.

The evidence that Nash mentions includes studies by Barbara Starfield and her colleagues at Johns Hopkins University. In a 2005 Health Affairs paper, they showed that a higher ratio of primary care physicians to the population is associated with a lower mortality rate from all causes and from heart disease and cancer; in contrast, having more specialists in a particular area does not decrease the overall mortality rate or deaths from cancer and heart disease.

Another study of Medicare data found that states where a higher percentage of physicians were PCPs had higher quality care and lower cost per beneficiary. This factor alone accounted for nearly half of the variation in Medicare spending from one state to another. A separate study found that in the areas of the country that had the most primary care providers, the average Medicare cost per beneficiary was a third lower than in areas with the least PCPs.

One reason for this is that primary care doctors provide comprehensive, continuous care, including preventive and routine chronic care. Chronic illnesses drive 90% of health costs, and some studies show that intensive primary care can reduce ER visits and hospital admissions and improve the health of chronically ill people.

Continue reading…

The COVID-19 Symptom Data Challenge Webinar

By INDU SUBAIYA & FARZAD MOSTASHARI

Following the launch of the COVID-19 Symptom Data Challenge on September 1st, we are excited to host a dedicated webinar providing further insights into the Challenge directly from key leaders representing our partner organizations at Facebook Data for Good, the Delphi Group at Carnegie Mellon University (CMU), the Joint Program on Survey Methodology at the University of Maryland (UMD), the Duke-Margolis Center for Health Policy, and Resolve to Save Lives, an initiative of Vital Strategies.

A stellar line up of speakers includes a raft of former government officials Mark McClellan (FDA & CMA), Tom Frieden (CDC), Farzad Mostashari (ONC) and many more, including Johns Hopkins’ Professor Caitlin Rivers, Carnegie Mellon’s Alex Reinhart & Facebook’s Head of Health Kang-Xing Jin.

If you are applying to the Challenge or would like to hear more about experts’ responses to COVID-19 and the importance of data during the pandemic, you do not want to miss this conversation! 

  • We will be discussing the following
    • Shortcomings of the existing tools for COVID-19 surveillance in the US
    • The case for better situational awareness of COVID activity
    • Overview of Symptom Data survey methodology
    • Preliminary analyses relating symptom trends to COVID intensity
    • Goals and operation of the Symptom Data Challenge

Tune in on Tuesday, September 8th at 1-2pm ET!

Event Registration Link: https://register.gotowebinar.com/register/6102626394063911951

Indu Subaiya is President of Catalyst @ Health 2.0. Farzad Mostashari is CEO of Aledade and Chair of the COVID-19 Symptom Data Challenge

assetto corsa mods